当前位置: 首页 » 论文全文
←返回首页
期刊信息:
《药学服务与研究》2017年, 第17卷, 第5期, 第339-342页
标题:
对糖尿病足合并肝肾功能不全患者的药学服务
DOI:
10.5428/pcar20170506
作者:
1. 吴慧1(1.江苏省盐城市第一人民医院药剂科 江苏盐城 224001 [email protected])
2. 2(2.上海交通大学附属第一人民医院临床药学科 上海 200080 )
3. 石卫峰2(2.上海交通大学附属第一人民医院临床药学科 上海 200080 [email protected])
摘要:
摘要  目的:探讨临床药师对于糖尿病足感染合并肝、肾功能不全患者的规范化服务方式和模式。方法:临床药师通过参与一例糖尿病足感染合并肝、肾功能不全患者的治疗过程,对患者的降糖药物、抗菌药物、抗乙肝病毒药物等方面提出参考意见,并提供个体化药学服务。结果:临床药师通过全程药学服务,及时发现并解决相关药物治疗问题,促进临床合理用药。结论:临床药师融入治疗团队,开展药学服务,有利于促进临床合理用药。
欢迎阅读《药学服务与研究》!您是该文第 98 位读者!
若需在您的论文中引用此文,请按以下格式著录参考文献:
中文著录格式 吴慧1,2,石卫峰2. 对糖尿病足合并肝肾功能不全患者的药学服务[J]. 药学服务与研究. 2017; 17(5): 339-342.
英文著录格式 WU Hui1,2,SHI WeiFeng2. Pharmaceutical care for the patient with diabetic foot infection complicated with hepatic and renal dysfunctions[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2017; 17(5): 339-342.
参考文献:
1. American Diabetes Association. Standards of medical care in diabetes-2016[J].Diabetes Care,2016,39(6):e88-e89.
2. McGuire H,Longson D,Adler A,et al. Management of type 2 diabetes in adults: summary of updated NICE guidance[J]. BMJ,2016,353:i1575.
3. Josse R G,Chiasson J L,Ryan E A,et al.Acarbose in the treatment of elderly patients with type 2 diabetes[J]. Diabetes Res Clin Pract,2003,59:37-42.
4. 母义明,纪立农,宁光,等.二甲双胍临床应用专家共识[J].中国糖尿病杂志,2014,22(8):673-681.
5. Wukich D K,Armstrong D G,Attinger C E,et al. Inpatient management of diabetic foot disorders: a clinical guide[J]. Diabetes Care,2013,36(9):2862-2871.
6. Zubair M,Malik A,Ahmad J. Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India[J].Foot (Edinb),2011,21(1):6-14.
7. 刘亚军,侯健红,袁明远.糖尿病足感染病原菌分布特点研究[J].中华医院感染学杂志,2014,24(4):833-834,840.
8. 陈雄威,郑柳娟,李唯佳,等.糖尿病足感染病原菌特点分析[J].中华医院感染学杂志,2014,24(1):76-77,80.
9. 王威,岳妍,郝莉莉,等.微生态制剂治疗抗生素相关性腹泻临床研究[J].中华医院感染学杂志,2016,26(6):1258-1260.
10. Hempel S,Newberry S J,Maher A R,et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis[J]. JAMA,2012,307(18):1959-1969.
11. Kogan M. Probiotics and antibiotic-associated diarrhoea[J]. Lancet,2014,383(9911):29-30.
12. 胡坚方,邵琴,汪照函,等. 乙型肝炎肝硬化腹水患者腹内压与醛固酮相关性分析[J].中华临床医师杂志(电子版),2015,9(12):2314-2317.
13. Runyon B A. Introduction to the revised American Association for the study of liver diseases practice guideline management of adult patients with ascites due to cirrhosis 2012[J]. Hepatology,2013,57(4):1651-1653.
14. DENG HouLiang,YIN JinJin,ZHANG JingJing,et al. Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy[J]. Endocrine,2014,46(3):445-454.
15. JIANG DeQi,LI MingXing,Wang Yan,et al. Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: a meta-analysis[J].Neurosci Lett,2015,594:23-29.
16. Hotta N,Kawamori R,Fukuda M,et al. Long-term clinical effects of epalrestat,an aldose reductase inhibitor,on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy[J].Diabet Med,2012,29(12):1529-1533.